Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	-205.22	-266.54	-87.33
Graham Fair Price	-25.82	0.25	0.34
PEG	121.99	1.49	0.67
Price/Book	34.59	39.82	29.59
Price/Cash Flow	-31.17	-138.24	-105.39
Prices/Earnings	4.70	-17.68	-18.56
Price/Sales	-22.04	36.72	47.10
Price/FCF	-31.17	-138.24	-105.39
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	8.74	0.65	0.60
Operating Margin	49.03	-0.24	-0.46
ROA	0.72	-0.07	-0.07
ROE	-0.40	-0.56	-41.23
ROIC	-0.08	-0.07	5.65
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	< 0.005	0.03	-86.14
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.11	0.41	267.79
EPS QOQ	0.28	0.12	-57.07
FCF QOQ	-0.36	0.31	-12.58
Revenue QOQ	0.14	0.16	11.83
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	35.63	37.98	6.59
Days Sales Outstanding (DSO)	43.52	39.87	-8.41
Inventory Turnover	2.53	2.37	-6.18
Debt/Capitalization	0.60	0.70	15.21
Quick Ratio	1.15	2.19	90.46
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	0.11	0.07	-37.58
Cash	0.17	0.13	-22.71
Capex	< 0.005	< 0.005	56.70
Free Cash Flow	-0.03	-0.02	35.95
Revenue	0.07	0.08	7.76
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	1.25	2.42	93.54
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-0.12	-2.97	-2308.25
Naive Interpretation	Member

06 - Financial Health · Bad

Rating